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Introduction
The first description of Kaposi’s
sarcoma (KS) was by Kaposi in
1872,1 who reported an unusual
tumour consisting of small brown-
ish-red cutaneous nodules, mainly
involving the skin of lower extrem-
ities in a multifocal fashion. 
The development of KS is relat-
ed to several factors: genetics due
to race and geographical distribu-
tion and infection because KS is
found principally in patients with
acquired immunodeficiency syn-
drome (AIDS). 
Infection by HHV-8, a new
human herpes virus described by
Chang in 1994,2 was considered
necessary but not sufficient for KS
development after HHV-8 DNA
was found in tissues of patients
affected by KS. The development
of KS also requires compromised
immune status.
Head and neck involvement in
Kaposi’s sarcoma (KS) is not
unusual.3 However, laryngeal
involvement is a somewhat infre-
quent manifestation. The literature
describes about 50 cases of laryn-
geal KS.
There are four types of epi-
demiological KS: AIDS-related or
epidemic, iatrogenic, African or
endemic, and the classic or
Mediterranean type. Three clinical
forms of KS have been noted:
localised nodular, locally aggres-
sive and generalised. HIV-nega-
tive patients with KS of the larynx
have been reported.4,5
Males seem to be affected most
(91%). The majority of patients
with laryngeal KS have advanced
HIV infection and were antiretro-
virally naive. 
Presenting symptoms may
include hoarseness, throat discom-
fort, cough, dysphagia, stridor and
dyspnoea. Laryngoscopy may
show laryngeal oedema or more
often a purple vascular mass
lesion. 
We report on the first case in
the literature in English of KS in
Morgagni’s ventricle.
Case report
A 65-year-old white male com-
plaining of cough and hoarseness
over the past three months attended
the emergency room of our
department for episodic dyspnoea
and stridor. The history was nega-
tive for cigarette smoking and
alcohol consumption. The patient
presented with dysphonia and
inspiratory stridor. The indirect
laryngoscopy showed a reddish
sessile mass arising from the supe-
rior aspect of the right true vocal
cord. The diameter of the lesion at
the largest point was 1.5 cm,
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 compromising the respiratory
 passage. Vocal cord motility was
normal, as was the rest of the
mucosa. Head and neck clinical
examination did not reveal lymph
node disease. 
The patient underwent an urgent
tracheotomy because of the stridor,
low oxygen saturation (average of
93%) and severe dyspnoea.
Pre-operative routine blood
tests results were normal, as were
thoracic radiographs.
The patient underwent a direct
microlaryngoscopy, revealing that
the true origin of the lesion was
above the arcuate line in the
 fundus of the right Morgagni’s
ventricle. The lesion was
 completely excised (Figure 1) by
means of laser-assisted surgery.
The tracheostomy was then closed
in the same intervention. 
Histopathology revealed the
proliferation of neoplastic spindle
cells arranged in intersecting fas-
cicles, which form slit-like vascu-
lar spaces of various dimensions
containing red cells (Figure 2).
The specimens were positive to
immunostain with CD-31 and
CD-34. Nuclear immunoreactivity
for HHV-8 was present, con -
firming the suspected diagnosis of
KS (Figure 3). 
The patient was then readmitted
for further analysis and to evaluate
the possibility of HIV infection.
No signs of HIV infection were
found. Blood tests were repeated
and ELISA examination for HIV,
CMV and EBV viruses were also
performed. All values were in the
normal range. No virus infection
was found. 
A total body dermatological
examination was then conducted,
showing typical KS nodular
lesions on both feet (Figure 4).
The definitive diagnosis of
Mediterranean or classic KS was
made.
The patient was then followed-
up. After one year, no recurrent
laryngeal lesions were detected,
Figure 1
Laryngeal Kaposi’s Sarcoma mass excised
Figure 2
Neoplastic cells showing nuclear immunoreactivity for HHV-8.
(Strept-ABC; original magnification 400×).
Figure 3
This section shows the proliferation of the neoplastic spindle
cells arranged in intersecting fascicles which form slit-like vas-
cular spaces of various dimensions containing red cells.
(Hematoxilin-Eosin staining; original magnification 200×).
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and the skin lesion did not show
any change. 
Discussion
Mediterranean type or classic KS
occurs in the older population of
the Mediterranean area and it
affects men 15 times more often
than women. The nodular lesions
are mainly situated in the lower
extremities; they are indolent and
infrequently cause morbidity.
Conversely, the epidemic form of
KS occurs in immunocompro-
mised subjects (AIDS-related).
The lesions in this form are
aggressive and multicentric. 
About 40% of AIDS patients
will develop KS during the course
of the disease, and two-thirds of
these patients will have head and
neck involvement.6
The lesions are reddish-purple,
multicentric macules and nodules.
Histologically, the typical features
of KS are spindle-shaped cells
with numerous vascular channels
and extravasated erythrocytes.
Deposits of haemosiderin are
present in a collagen stroma. An
inflammatory infiltrate may be
present. Immunostain is per-
formed with HHV-8 antibodies to
confirm the viral infection and
hence the diagnosis.
The two largest series of
patients affected by laryngeal KS
have been reported by Abramson et
al.7 in 1970 with 13 patients and by
Mochloulis8 in 1996 with 17 cases.
Classic KS of the larynx is a rare
Figure 4
Nodular skin lesions on the right foot,
 typical of Classic Kaposi’s Sarcoma.
Table I
The literature relating to Kaposi’s sarcoma, including the present case*
Author Year Cases Site involved Local treatment Type 
Reynolds10 1965 1 Arytenoids-Epiglottis Tracheotomy Classic
Coyas11 1983 1 Larynx Tracheotomy Classic
Abramson7 1970 13 Larynx Classic
Moritsch16 1978 1 Larynx-Hypopharynx Tracheotomy Classic
Abemayor3 1983 1 Epiglottis Epidemic
Gnepp12 1984 2 Anterior commissure (1)
Larynx-Hypopharynx (1)
Excision (1)
Tracheotomy (1)
Epidemic
Weidauer17 1986 1 Larynx Excision Epidemic
Levy18 1990 1 Glottic Epidemic
Friedman13 1996 6 Larynx Intralesional vinblastine (6)
Tracheotomy (1)
Epidemic
Mochloulis8 1996 17 Supraglottic (11)
Glottic (8)
Subglottic (3)
Tracheotomy (1)
Radiotherapy (5)
Epidemic
Schiff19 1997 2 Epiglottis (2) Biopsy (1) excision (1) Epidemic
Beitler9 1996 1 Larynx Tracheotomy (1) Epidemic
Gras20 1999 1 Supraglottic Intralesional injection Epidemic
Alkhuja21 2001 1 Larynx Tracheotomy Epidemic
Ares22 2005 1 Larynx Tracheotomy Epidemic
Angouridakis4 2006 1 Vocal cord Excision Classic
Ashurov5 2007 1 Larynx Classic
Dispenza* 2008 1 Larynx Tracheotomy and excision Classic
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entity with less than 20 cases
reported in the literature (Table 1). 
The clinical presentation of
laryngeal KS is variable, de -
pending on the site and the stage
of the disease. The symptoms
range from dysphonic voice to
stridor and dyspnoea due to upper
airway obstruction. In the litera-
ture, ten cases of laryngeal KS
needed tracheotomy,8-13 including
the present case (Table 1).
Diagnostic biopsies were per-
formed without complications in
several patients, but biopsies of
such vascular lesions have been
associated with brisk and poten-
tially fatal bleeding.8
The diagnosis of KS is general-
ly made after histopathology, par-
ticularly in Classic KS, because of
the lack of manifest extralaryngeal
symptoms. In AIDS patients, the
index of suspicion is higher than
in other patients affected by the
Mediterranean form.
Therapeutic options include:
low-dose irradiation, intralesional
chemotherapy, ablation and sys-
temic therapy if there is dissemi-
nated disease. Obstructing laryn-
geal lesions require urgent inter-
vention with tracheotomy.
Depending upon the location of
the lesion, a tracheotomy may
contribute to mortality as a result
of fatal haemorrhaging.9 A tra-
cheotomy is generally adopted in
these patients when transoral intu-
bation for general anaesthesia is
difficult or impossible, and in
cases of severe dyspnoea.
Furthermore, surgeons should
bear in mind that Kaposi’s nodules
may be bleeding lesions, and so
intraoperative haemorrhaging
during transoral surgery may be
well managed if the airways are
saved. Surgical excision is adopted
for isolated lesions and for those
obstructing the airway. The tran-
soral modality for the surgical
removal of the lesions is the first
choice because it allows for the
prompt and good visualisation of
the glottic plane and rapid postop-
erative healing.
In our case the lesion was
removed after airway patency
was restored by tracheotomy. Tra -
che otomy may be closed once the
lesion is removed. 
Friedman et al. adopted the
intralesional injection of Vinblas -
tine sulphate, with an appreciable
response in over 75% of cases.
Only one patient required a tra-
cheotomy for upper airway
obstruction.13
The Mediterranean type of KS
does not generally contribute to
patient mortality and the treat-
ment of asymptomatic laryngeal
lesions may be conservative8, as in
other laryngeal lesions.14,15 In the
 epidemic type, death is secondary
to other AIDS-related disease
processes.
Conclusion
Laryngeal KS is a rare clinical
entity. To the best of our knowl-
edge this is the first case reported
in the English literature of KS
affecting the laryngeal ventricle.
The clinical investigation generally
shows a mass without malignant
features. The definitive diagnosis
is established after histopathology,
but the index of suspicion is high,
especially in AIDS patients. It
must be included in the differen-
tial diagnosis of pigmented laryn-
geal lesions. Urgent treatment
may be required in cases of acute
stridor due to an occluding mass.
Classic KS is not an aggressive
disease and patients usually die
of other diseases, but follow-up
is mandatory to prevent loco-
regional recurrence or new pri-
mary lesions.
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